Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Foreign Affairs Discussion Group -- Ignore unavailable to you. Want to Upgrade?

To: Win Smith who wrote (53235)	10/19/2002 5:04:46 PM
From: Doc Bones	Respond to of 281500

people are grasping for patterns in the sniper's previous actions Connecting the dots... Henry Niman is an SI member, best known as a champion of a controversial biotech stock, Ligand LGND. He had some success dividing the anthrax attacks into two groups, perhaps tried it again with the sniper. ph.ucla.edu Nov 2, 2001 Dr. Henry Niman, a molecular biologist at NetCog, an online financial newsletter, wrote in an article on Wednesday that the existing anthrax cases fell into two clusters following the Sept. 18 and Oct, 9 mailings. Dr. Niman said it appeared that the mailings were conducted like experiments that had been modified in the light of experience. After official warnings against letters with no return address, like those of the Sept. 18 mailings, a return address was put on the Daschle letter, Dr. Niman noted. Dr. Niman said he expected that in another attack a different location would be used if the attack were by mail, or a different method of dispersion. ------- He had some tangential involvement in the anthrax investigation himself. Dr. Weisfogel did not have anthrax: it was a long shot at best. query.nytimes.com Nov. 10, 2001 Dr. Weisfogel said he had continued to feel ill after the skin lesion resolved itself and he checked into John F. Kennedy Hospital in Edison on Oct. 20. Doctors there gave him a diagnosis of spinal meningitis and treated him with doxycycline, an antibiotic that is also recommended for anthrax. Dr. Weisfogel said he was persuaded to get his blood tested for antibodies to anthrax, a sign of past exposure to the bacterium, by a distant relative, Dr. Henry Niman, a molecular biologist who now works at NetCog, an online financial newsletter, and has taken a keen interest in the anthrax scare. At first the C.D.C. office in New Jersey declined to test his blood, Dr. Weisfogel said, on the grounds that his case had occurred before the first known mailing of anthrax and that he had no connection with the postal system. The office also told him, he said, that a positive result would be meaningless because the current blood test, though highly sensitive to anthrax, also gave many false positives. After further discussions the office agreed on Thursday to undertake the test. ---- The Michael's Stores (MIK - another controversial stock <g>) connection seems a bit of a stretch. Doc